| Company Name: | AdCare Health Systems, Inc. | | Ticker Symbol: | ADK | | | WWW Address: | www.adcarehealth.com |
| CEO: | Boyd P. Gentry | | No. of Employees: | 3,450 |
| Common Issue Type: | CS | | Business Description: | The Company is a developer, owner and manager of retirement communities, assisted living facilities, skilled nursing facilities and home health care services in the state of Ohio.
|
| | | Industry Information: | HEALTH SERVICES - Long-Term Care Facilities [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 4.6 |  0.0 | - | - | | 4.82 | 4.75 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 67.4 | 14.7 | 1.78 | 0.00 | 0.00 | 0.0 | 0.0 | 6.26 - 3.23 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 4.79 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 67.4 | mil |
| Latest Shares Outstanding | 14.7 | mil |
| Earnings pS (EPS) | 0.00 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 10.8 | mil |
| Float as % of Shares Outstanding | 84.3 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | -0.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 9.2 | % |
| EBITDA Margin | 9.7 | % |
| Pre-Tax Profit Margin | -2.4 | % |
| Assets Turnover | 1.1 | % |
| Return on Assets (ROA) | -3.1 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -4.0 | % |
| Current Ratio | 1.0 | |
| Leverage Ratio (Assets/Equity) | 11.2 | |
| Interest Cover | 0.6 | |
| Total Debt/Equity (Gearing Ratio) | 8.55 | |
| LT Debt/Total Capital | 89.0 | % |
| Working Capital pS | -0.16 | $ |
| Cash pS | 0.67 | $ |
| Book-Value pS | 1.44 | $ |
| Tangible Book-Value pS | 0.68 | $ |
| Cash Flow pS | 0.18 | $ |
| Free Cash Flow pS | -0.93 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.33 | |
| Price/Tangible Book Ratio | 7.07 | |
| Price/Cash Flow | 26.9 | |
| Price/Free Cash Flow | -5.2 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Stock Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 4.1 | 105 | 253 | 940 |
| 4 Weeks | 5.05 | 4.41 | 5.08 | -5.7 | 96 | 569 | 10,239 |
| 13 Weeks | 6.26 | 3.66 | 4.30 | 11.4 | 106 | 710 | 43,996 |
| 26 Weeks | 6.26 | 3.66 | 4.50 | 6.5 | 92 | 510 | 62,682 |
| 52 Weeks | 6.26 | 3.23 | 3.24 | 47.9 | 121 | 478 | 118,492 |
| YTD | 6.26 | 3.66 | - | 0.8 | 88 | 541 | 61,084 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 4.72 | 4.68 | 5.07 | 4.72 | 4.69 | 1.78 | 1.41 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 63.12 | 88.4 | 107.29 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 100.86 | NA | 275.84 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 41.4 | 6.5 | 184.3 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.59 | 0.50 | 0.59 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -3.74 |
| Current Ratio | 0.8 |
| Quick Ratio (Acid Test) | 0.7 |
| Liquidity Ratio (Cash) | 0.29 |
| Receivables Turnover | 9.1 |
| Average Collection Period | 40 |
| Working Capital/Equity | -53.2 |
| Working Capital pS | -0.63 |
| Cash-Flow pS | 0.00 |
| Free Cash-Flow pS | 0.00 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 0.96 |
| Financial Leverage Ratio (Assets/Equity) | 14.2 |
| Debt Ratio | 89.3 |
| Total Debt/Equity (Gearing Ratio) | 10.37 |
| LT Debt/Equity | 9.06 |
| LT Debt/Capital Invested | 86.8 |
| LT Debt/Total Liabilities | 71.3 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 7.59 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 6.95 |
| Tobin's Q Ratio | 0.28 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 28.10 |
| Enterprise Value (EV)/Free Cash Flow | 0.00 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 7.07 |
| Price/Book Ratio - LTM | 3.33 |
| Price/Cash Flow Ratio | 26.9 |
| Price/Free Cash Flow Ratio - LTM | -5.2 |
| Price/Sales Ratio | 0.33 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 10.79 |
| Current Liabilities pS | 4.19 |
| Tangible Book Value pS - LTM | 0.68 |
| Book Value pS - LTM | 1.44 |
| Capital Invested pS | 12.61 |
| Cash pS - LTM | 0.67 |
| Cash Flow pS - LTM | 0.18 |
| Free Cash Flow pS - LTM | -0.93 |
| Earnings pS (EPS) | 0.00 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.00 |
| Free Cash Flow Margin 5YEAR AVG | -5.26 |
| Net Profit Margin | -3.3 |
| Net Profit Margin - 5YEAR AVRG. | -3.7 |
| Equity Productivity | 12.25 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.16 |
| Return on Capital Invested (ROCI) | -3.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -4.3 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | -2.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | -3.3 |
| Gross Profit Margin | 9.2 |
| Gross Profit Margin - 5YEAR AVRG. | 29.2 |
| EBITDA Margin - LTM | 9.7 |
| EBIT Margin - LTM | 3.8 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -3.1 |
| Effective Tax Rate | 0.6 |
| Effective Tax Rate - 5YEAR AVRG. | -3.4 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 47 |
| Revenue per Employee | |
| Net Income per Employee | |
| Average Collection Period | 47 |
| Receivables Turnover | 9.1 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 14.37 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | -23.03 |
| Fixed Assets Turnover | 1.09 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 13.21 |
| Revenue per $ Plant | 1.32 |
| Revenue per $ Common Equity | 12.25 |
| Revenue per $ Capital Invested | 1.16 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 23.4 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
